- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bukwang Pharm (003000)
Bukwang Pharm stock price live, this page displays KS 003000 stock exchange data. View the 003000 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bukwang Pharm real time stock price chart below.
What Is the Bukwang Pharm Stock Price Today?
The Bukwang Pharm stock price today is 3,945.
What Is the Stock Symbol for Bukwang Pharm?
The stock symbol for Bukwang Pharm is "003000."
What Stock Exchange Does Bukwang Pharm Trade On?
Bukwang Pharm is listed and trades on the Seoul stock exchange.
Is Bukwang Pharm a Good Stock to Buy?
Determining whether Bukwang Pharm—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 003000 quote. (ISIN: KR7003000007)
What Is the Bukwang Pharm Stock Price Today?
The Bukwang Pharm stock price today is 3,945.
What Is the Stock Symbol for Bukwang Pharm?
The stock symbol for Bukwang Pharm is "003000."
What Stock Exchange Does Bukwang Pharm Trade On?
Bukwang Pharm is listed and trades on the Seoul stock exchange.
Is Bukwang Pharm a Good Stock to Buy?
Determining whether Bukwang Pharm—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 003000 quote. (ISIN: KR7003000007)
Seoul
Currency in KRW
3,945
+95(+2.47%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,830
3,955
52 wk Range
3,200
5,160
003000 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,8303,955
52 wk Range
3,2005,160
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.27%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.27%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
003000 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Bukwang Pharm Company Profile
Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments. The company also provides ethical drugs, including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia; over-the-counter drugs, such as fever and pain relief medication, gastrointestinal medication, cold medication, laxatives for constipation, collagen supplements, multivitamin supplements, mouthwash, topical gels, oral health supplements, and omega-3 supplements; and personal products comprising toothpastes, toothbrushes, and other oral care products; nutraceuticals; health functional foods; and quasi drugs. In addition, it offers products for various threptic areas, including endocrinology, gastroenterology, cardiology, oncology, central nervous system, iron supplements, neuropsychiatry, respiratory/allergy, dermatology, urology, and other treatment areas. Further, the company’s development pipeline comprises Lurasidone for the treatment of schizophrenia and bipolar depression; JM-010, for treating dyskinesia in parkinson’s disease; SOL-804, which is used for the treatment of metastatic castration resistant prostate cancer; AhR Inhibitor for solid tumors; PKR Inhibitor for neurodegenerative disorders; and PD Program for parkinson’s disease. Bukwang Pharmaceutical Co., Ltd. was founded in 1960 and is headquartered in Seoul, South Korea.
Compare 003000 to Peers and Sector
Metrics to compare | 003000 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship003000PeersSector | |
|---|---|---|---|---|
P/E Ratio | 40.0x | 2.7x | −0.6x | |
PEG Ratio | 0.25 | 0.01 | 0.00 | |
Price/Book | 1.1x | 1.0x | 2.6x | |
Price / LTM Sales | 2.1x | 1.1x | 3.4x | |
Upside (Analyst Target) | - | 37.3% | 42.0% | |
Fair Value Upside | Unlock | 6.6% | 5.0% | Unlock |
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
11.00 / --
Revenue / Forecast
47.81B / --
People Also Watch
FAQ
What Is the Bukwang Pharm (003000) Stock Price Today?
The Bukwang Pharm stock price today is 3,945
What Stock Exchange Does Bukwang Pharm Trade On?
Bukwang Pharm is listed and trades on the Seoul Stock Exchange stock exchange.
What Is the Stock Symbol for Bukwang Pharm?
The stock symbol for Bukwang Pharm is "003000."
Does Bukwang Pharm Pay Dividends? What’s The Current Dividend Yield?
The Bukwang Pharm dividend yield is 1.27%.
What Is the Bukwang Pharm Market Cap?
As of today, Bukwang Pharm market cap is 389.23B.
What Is Bukwang Pharm's Earnings Per Share (TTM)?
The Bukwang Pharm EPS (TTM) is 130.59.
When Is the Next Bukwang Pharm Earnings Date?
Bukwang Pharm will release its next earnings report on Mar 25, 2026.
From a Technical Analysis Perspective, Is 003000 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Bukwang Pharm Stock Split?
Bukwang Pharm has split 16 times.
How Many Employees Does Bukwang Pharm Have?
Bukwang Pharm has 615 employees.
What is the current trading status of Bukwang Pharm (003000)?
As of Jan 25, 2026, Bukwang Pharm (003000) is trading at a price of 3,945, with a previous close of 3,850. The stock has fluctuated within a day range of 3,830 to 3,955, while its 52-week range spans from 3,200 to 5,160.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.